{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:27:32Z","timestamp":1762867652270,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.endien.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T17:57:47Z","timestamp":1634061467000},"page":"389-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The presence of microvascular complications is associated with a poor evolution of metabolic control in patients with type 1 diabetes mellitus"],"prefix":"10.1016","volume":"68","author":[{"given":"Florentino","family":"Carral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jes\u00fas","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coral","family":"Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2021.10.001_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.10.001_bib0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jdiacomp.2018.05.007","article-title":"What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?","volume":"32","author":"Herman","year":"2018","journal-title":"J Diabet Complications"},{"key":"10.1016\/j.endien.2021.10.001_bib0015","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.2337\/dc20-S006","article-title":"Glycemic targets: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.10.001_bib0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(19)31142-0","article-title":"Advances in technology for management of type 1 diabetes","volume":"394","author":"Beck","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.endien.2021.10.001_bib0025","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/dme.12676","article-title":"Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison","volume":"32","author":"McKnight","year":"2015","journal-title":"Diabet Med"},{"year":"2019","series-title":"National diabetes audit","author":"NHS Digital","key":"10.1016\/j.endien.2021.10.001_bib0030"},{"key":"10.1016\/j.endien.2021.10.001_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2042018819830867","article-title":"Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases","volume":"10","author":"Van Mark","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.endien.2021.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.118.037454","article-title":"Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus","volume":"139","author":"Rawshani","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.endien.2021.10.001_bib0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00125-019-4900-7","article-title":"Glycaemic control trends in people with type 1 diabetes in Scotland 2004\u20132016","volume":"62","author":"Mair","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.endien.2021.10.001_bib0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2021.10.001_bib0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/clinem\/dgaa015","article-title":"Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry","volume":"105","author":"Shah","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2021.10.001_bib0065","first-page":"1","article-title":"Association of diet and lifestyle with glycated haemoglobin in type 1 diabetes participants in the EURODIAB prospective complications study","author":"Balk","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0070","first-page":"92","article-title":"Diabetes mellitus tipo 1 y LADA: Descripci\u00f3n y an\u00e1lisis de una serie de 1782 pacientes atendidos en consulta monogr\u00e1fica","volume":"66","author":"Mart\u00ednez","year":"2019","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.endonu.2012.07.003","article-title":"Situaci\u00f3n de control metab\u00f3lico y pautas de tratamiento en pacientes con diabetes tipo 1 en Castilla-La Mancha: estudio de diabetes tipo 1 en Castilla-La Mancha","volume":"59","author":"Sastre","year":"2012","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0080","first-page":"17","article-title":"Factores relacionados con la prescripci\u00f3n de tratamiento hipolipemiante en pacientes con diabetes mellitus tipo 1 en Espa\u00f1a","volume":"66","author":"Bellido","year":"2019","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0085","first-page":"84","article-title":"Caracter\u00edsticas cl\u00ednicas y manejo de la diabetes tipo 1 en Espa\u00f1a. Estudio SED1","volume":"66","author":"G\u00f3mez Peralta","year":"2019","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1575-0922(08)75840-6","article-title":"\u00bfEs posible alcanzar los objetivos de control en la diabetes tipo 1?","volume":"55","author":"Baena","year":"2008","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.endonu.2016.03.008","article-title":"Situaci\u00f3n cl\u00ednica de una cohorte de pacientes con diabetes tipo 1 m\u00e1s de 2 d\u00e9cadas despu\u00e9s del inicio. Resultados de un programa espec\u00edfico de seguimiento en una unidad de referencia","volume":"63","author":"Amor","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0100","first-page":"83","article-title":"Registro de diabetes tipo 1 en el Hospital Comarcal D\u2019Inca","volume":"66","author":"Cabrer","year":"2019","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.endonu.2015.02.002","article-title":"Epidemiolog\u00eda en la diabetes tipo 1: ayudando a encajar las piezas del puzle","volume":"62","author":"Forga","year":"2015","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.endinu.2018.01.003","article-title":"La incidencia de diabetes tipo 1, en Navarra, se ha estabilizado en los \u00faltimos 8 a\u00f1os","volume":"65","author":"Forga","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.avdiab.2015.02.002","article-title":"Control gluc\u00e9mico y complicaciones cr\u00f3nicas a 20 a\u00f1os del comienzo de la diabetes tipo 1. Resultados de una unidad especializada","volume":"31","author":"Colom","year":"2015","journal-title":"Av Diabetol"},{"key":"10.1016\/j.endien.2021.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2021.10.001_bib0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.2014.16107","article-title":"Association between 7 years of intensive treatment of type 1 diabetes and longterm mortality","volume":"313","author":"Orchard","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.endien.2021.10.001_bib0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2008.07.052","article-title":"DPV-Wiss Study Group. Smoking and metabolic control in adolescents with type 1 diabetes","volume":"154","author":"Hofer","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.endien.2021.10.001_bib0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.endinu.2019.02.004","article-title":"Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit","volume":"66","author":"Amor","year":"2019","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2021.10.001_bib0140","first-page":"257","article-title":"Alteraciones de la presi\u00f3n arterial en pacientes con diabetes tipo 1","volume":"25","author":"V\u00edlchez","year":"2009","journal-title":"Av Diabetol"},{"key":"10.1016\/j.endien.2021.10.001_bib0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF03347057","article-title":"Alterations in arterial pressure in patients with type 1 diabetes is associated with long-term poor metabolic control and a more atherogenic lipid profile","volume":"34","author":"Vilchez","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endien.2021.10.001_bib0150","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jdiacomp.2016.05.021","article-title":"Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus","volume":"30","author":"Mateo","year":"2016","journal-title":"J Diabet Complications"},{"key":"10.1016\/j.endien.2021.10.001_bib0155","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/HJH.0b013e3283531eaf","article-title":"Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis","volume":"30","author":"Bliziotis","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.endien.2021.10.001_bib0160","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/dc18-1446","article-title":"Mortality, and cardiovascular outcomes in type 1 diabetes: findings against an obesity paradox","volume":"42","author":"Edqvist","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diacare.26.4.1258","article-title":"Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes","volume":"26","author":"Hovind","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.10.001_bib0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/dc14-1203","article-title":"Impact of HbA1c followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)","volume":"38","author":"Nordwall","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.10.001_bib0175","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018021000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018021000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:14:54Z","timestamp":1762866894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018021000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2530018021000810"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2021.10.001","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The presence of microvascular complications is associated with a poor evolution of metabolic control in patients with type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2020.07.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}